cs.CVMar 17, 2026

Efficient AI-Driven Multi-Section Whole Slide Image Analysis for Biochemical Recurrence Prediction in Prostate Cancer

Authors: Yesung Cho, Dongmyung Shin, Sujeong Hong, Jooyeon Lee, Seongmin Park, Geongyu Lee, Jongbae Park, Hong Koo Ha

Organizations: OmixAI Co. Ltd., Republic of Korea, 02636. · Oncocross Co. Ltd., Republic of Korea, 05836. · Department of Urology, School of Medicine, Pusan National University, Republic of Korea, 50612 · Department of Medicine, School of Medicine, Kyunghee University, Republic of Korea, 02447

Abstract

Prostate cancer is one of the most frequently diagnosed malignancies in men worldwide. However, precise prediction of biochemical recurrence (BCR) after radical prostatectomy remains challenging due to the multifocality of tumors distributed throughout the prostate gland. In this paper, we propose a novel AI framework that simultaneously processes a series of multi-section pathology slides to capture the comprehensive tumor landscape across the entire prostate gland. To develop this predictive AI model, we curated a large-scale dataset of 23,451 slides from 789 patients. The proposed framework demonstrated strong predictive performance for 1- and 2-year BCR prediction, substantially outperforming established clinical benchmarks. The AI-derived risk score was validated as the most potent independent prognostic factor in a multivariable Cox proportional hazards analysis, surpassing conventional clinical markers such as pre-operative PSA and Gleason score. Furthermore, we demonstrated that integrating patch and slide sub-sampling strategies significantly reduces computational cost during both training and inference without compromising predictive performance, and generalizability of AI was confirmed through external validation. Collectively, these results highlight the clinical feasibility and prognostic value of the proposed AI-based multi-section slide analysis as a scalable tool for post-operative management in prostate cancer.

Explore similar work

CardsList
  1. Deep Learning From Routine Histology Improves Risk Stratification for Biochemical Recurrence in Prostate Cancer

    Mar 15, 2026Clément Grisi, Khrystyna Faryna, Nefise Uysal +11Clinical Risk PredictionOncology

  2. CHIMERA Challenge: Biochemical Recurrence Prediction in Prostate Cancer Patients using multimodal datasets

    Aug 21, 2026Robert N. Spaans, Catherine Chia, Tongjie Wang +7Clinical Outcome PredictionMedical Image Benchmarks